A phase II trial of nab-paclitaxel (ABI-007) and carboplatin in patients with unresectable stage IV melanoma- A North Central Cancer Treatment Group Study, N057E1
- Citation:
- Cancer vol 117 (8)
- Year:
- 2011
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Program:
- OGC
- Primary Committee:
- Experimental
- Sec. Committees:
- Pharmas:
- Grants:
- U10 CA035267, U10 CA025224-25, U10 CA052352, U10 CA037417, N01 CA035431, U10 CA035269, CA-37404, CA-35090, CA-52352, CA-35195, U10 CA037404, N01 CA035119, U10 CA063848, U10 CA035195, CA-35103, CA-25224, CA-35113, U10 CA035101, U10 CA035113, CA-63848, U10 CA035415, U10 CA063849, CA-35415, U10 CA035431, U10 CA035119, CA-37417, CA-35269, CA-35101, U10 CA025224, U10 CA035090, CA-35267, CA-63849, U10 CA035103
- Corr. Author:
- Authors:
- Lisa A Kottschade Vera J. Suman Thomas Amatruda Robert R. McWilliams Bassam I. Mattar Daniel A Nikcevich Robert Behrens Tom R Fitch Anthony J Jaslowski Svetomir N Markovic
- Networks:
- Study
- NCCTG-N057E
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords:
- metastatic melanoma, nab-paclitaxel, carboplatin, chemotherapy, stage IV, unresectable